Can CBD capsules help you sleep? large trial seeks answers

NCT ID NCT05840822

Ongoing Symptom relief Sponsor: Avecho Biotechnology Source: ClinicalTrials.gov ↗

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This Phase 3 study tests whether nightly doses of CBD (75mg or 150mg) can reduce insomnia severity in adults over 8 weeks. Participants take capsules or a placebo, and researchers measure changes in sleep quality using a standard questionnaire and sleep efficiency. The goal is to provide reliable evidence on whether CBD is a safe and effective option for managing insomnia.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cannabidiol (CBD) capsules
What this could lead to: If successful, this could provide a well-studied, non-intoxicating option for people struggling with insomnia, potentially improving sleep quality and daytime function.
What could go wrong: This is a single Phase 3 trial; results may not confirm effectiveness. CBD can cause side effects like drowsiness or digestive issues, and long-term safety is not yet established.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSOMNIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

insomnia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INSOMNIA

Contacts and locations

Locations

Captain Stirling Medical Centre

Nedlands, Western Australia, 6009, Australia
Griffith University

Southport, Queensland, 4222, Australia
Key Health, CBD South

Sydney, New South Wales, 2000, Australia
Monash Health

Clayton, Victoria, 3168, Australia
Pioneer Clinical Research

North Sydney, New South Wales, 2060, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.